InvestorsHub Logo

Troymister

06/12/23 6:01 PM

#600804 RE: IlleNastase #600769

A little context here from the article you linked:

"Results are still a ways off: According to Ciesielski, the company doesn’t expect its earliest results from the Phase 2b trial until mid-2024, and the trial likely won’t be completed for another 18 to 24 months after that. If successful, the company will have to conduct a larger Phase 3 clinical trial."

But the article really does beg this question: NBC News gives this kind of attention to a Phase 2b trial while NWBO gets NO attention to a Phase 3 trial with very positive results? Why, why, why?